Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Vyluma logo — Committed to developing novel ophthalmic treatments for glob...

Vyluma

Committed to developing novel ophthalmic treatments for global unmet needs

Founded 2021 United States Bridgewater, United States 5 employees

General Information

Company Name Vyluma
Founded Year 2021
Location United States Bridgewater, United States +1
Employees 5
Social

Get notified when Vyluma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Vyluma

Vyluma is a startup founded in 2021, with a slogan that emphasizes their commitment to developing novel ophthalmic treatments to address global unmet needs. The company's name originates from languages across the globe, symbolizing their goal to serve a global population by providing effective pharmaceutical ophthalmic solutions. Although specific details about their industries and previous investments are not available at this time, Vyluma is based in the United States. As a potential investment opportunity, Vyluma's focus on addressing global unmet needs in ophthalmic treatments makes them a compelling prospect for venture capitalists seeking impactful healthcare solutions.

Taxonomy: ophthalmic treatments, global unmet needs, pharmaceutical solutions, ophthalmology, innovation, global population, novel treatments, Vyluma, eye care, vision healthcare, international, pharmaceutical development

No funding data available for Vyluma yet.

Get notified when Vyluma raises funding

Vyluma Alternatives & Competitors

Vyluma vs
pharma&
pharma& Austria

breathing new life into proven medicines

150 employees
Health Care, Health and Wellness
Vyluma vs
Eastern Biotech
Eastern Biotech

Advancing Medical Solutions for Diabetes and Obesity Through Rigorous Research and Development

Angel
51-200 employees
Biotechnology, Health Care
Vyluma vs
Daiichi Sankyo Japan
Daiichi Sankyo Japan Japan

Passion for Innovation. Compassion for Patients.

1708 employees
Biotechnology, Health Care

FAQ About Vyluma

Committed to developing novel ophthalmic treatments for global unmet needs
Vyluma was founded in 2021.
Vyluma is headquartered in Bridgewater, United States.
Vyluma has approximately 5 employees.
Top alternatives and competitors to Vyluma include pharma&, Eastern Biotech, Daiichi Sankyo Japan, Petrovax Pharm, CHEPLAPHARM. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vyluma and pharma& are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Vyluma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy